Michael Rice Sells 18,750 Shares of BioLife Solutions Inc (NASDAQ:BLFS) Stock

Share on StockTwits

BioLife Solutions Inc (NASDAQ:BLFS) CEO Michael Rice sold 18,750 shares of the stock in a transaction that occurred on Tuesday, September 8th. The stock was sold at an average price of $21.64, for a total value of $405,750.00. Following the completion of the transaction, the chief executive officer now directly owns 227,096 shares of the company’s stock, valued at $4,914,357.44. The sale was disclosed in a filing with the SEC, which is available at this link.

Michael Rice also recently made the following trade(s):

  • On Thursday, September 10th, Michael Rice sold 18,750 shares of BioLife Solutions stock. The shares were sold at an average price of $23.24, for a total value of $435,750.00.
  • On Wednesday, August 26th, Michael Rice sold 877 shares of BioLife Solutions stock. The shares were sold at an average price of $20.48, for a total value of $17,960.96.
  • On Thursday, August 13th, Michael Rice sold 18,750 shares of BioLife Solutions stock. The shares were sold at an average price of $18.64, for a total value of $349,500.00.
  • On Tuesday, August 11th, Michael Rice sold 18,750 shares of BioLife Solutions stock. The shares were sold at an average price of $19.91, for a total value of $373,312.50.
  • On Tuesday, July 14th, Michael Rice sold 18,750 shares of BioLife Solutions stock. The shares were sold at an average price of $18.67, for a total value of $350,062.50.
  • On Thursday, July 16th, Michael Rice sold 18,750 shares of BioLife Solutions stock. The shares were sold at an average price of $19.30, for a total value of $361,875.00.
  • On Friday, June 19th, Michael Rice sold 18,750 shares of BioLife Solutions stock. The shares were sold at an average price of $16.37, for a total value of $306,937.50.

BLFS stock opened at $23.77 on Friday. The business’s 50-day moving average price is $20.58 and its two-hundred day moving average price is $15.65. The firm has a market cap of $753.64 million, a PE ratio of 392.50, a P/E/G ratio of 78.50 and a beta of 1.70. BioLife Solutions Inc has a 1-year low of $7.37 and a 1-year high of $24.70.

BioLife Solutions (NASDAQ:BLFS) last posted its earnings results on Thursday, August 6th. The medical equipment provider reported ($0.01) earnings per share for the quarter. The business had revenue of $9.92 million for the quarter, compared to the consensus estimate of $9.68 million. BioLife Solutions had a return on equity of 1.49% and a net margin of 42.52%. On average, sell-side analysts expect that BioLife Solutions Inc will post 0.03 earnings per share for the current year.

Several institutional investors and hedge funds have recently added to or reduced their stakes in BLFS. FMR LLC acquired a new stake in shares of BioLife Solutions in the 1st quarter valued at about $2,684,000. UBS Group AG raised its stake in shares of BioLife Solutions by 27.4% in the 1st quarter. UBS Group AG now owns 15,839 shares of the medical equipment provider’s stock valued at $151,000 after purchasing an additional 3,406 shares during the period. BlackRock Inc. raised its stake in shares of BioLife Solutions by 7.2% in the 1st quarter. BlackRock Inc. now owns 595,328 shares of the medical equipment provider’s stock valued at $5,656,000 after purchasing an additional 39,861 shares during the period. Victory Capital Management Inc. raised its stake in shares of BioLife Solutions by 31.6% in the 1st quarter. Victory Capital Management Inc. now owns 6,128 shares of the medical equipment provider’s stock valued at $58,000 after purchasing an additional 1,470 shares during the period. Finally, JPMorgan Chase & Co. raised its stake in shares of BioLife Solutions by 144.1% in the 1st quarter. JPMorgan Chase & Co. now owns 43,185 shares of the medical equipment provider’s stock valued at $410,000 after purchasing an additional 25,494 shares during the period. 46.90% of the stock is currently owned by hedge funds and other institutional investors.

A number of equities research analysts recently weighed in on BLFS shares. HC Wainwright reaffirmed a “buy” rating and set a $17.00 price target on shares of BioLife Solutions in a report on Thursday, June 4th. Zacks Investment Research cut BioLife Solutions from a “hold” rating to a “sell” rating in a report on Wednesday. Stephens increased their price objective on BioLife Solutions from $23.00 to $24.00 and gave the company an “overweight” rating in a research report on Friday, May 15th. ValuEngine upgraded BioLife Solutions from a “hold” rating to a “buy” rating in a research report on Wednesday, August 19th. Finally, Benchmark lowered BioLife Solutions from a “buy” rating to a “hold” rating and set a $21.00 price objective on the stock. in a research report on Tuesday, August 11th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and nine have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $22.94.

BioLife Solutions Company Profile

BioLife Solutions, Inc develops, manufactures, and markets grade cell and tissue hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs in the United States. Its products are serum-free and protein-free solutions, which are formulated to reduce preservation-induced cell damage and death.

Further Reading: Why is the LIBOR significant?

Insider Buying and Selling by Quarter for BioLife Solutions (NASDAQ:BLFS)

Receive News & Ratings for BioLife Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

State of Tennessee Treasury Department Boosts Stake in AZZ Inc
State of Tennessee Treasury Department Boosts Stake in AZZ Inc
State of Tennessee Treasury Department Acquires 1,093 Shares of TTEC Holdings Inc
State of Tennessee Treasury Department Acquires 1,093 Shares of TTEC Holdings Inc
State of Tennessee Treasury Department Decreases Stock Holdings in Acuity Brands, Inc.
State of Tennessee Treasury Department Decreases Stock Holdings in Acuity Brands, Inc.
State of Tennessee Treasury Department Has $859,000 Stock Holdings in Barnes Group Inc.
State of Tennessee Treasury Department Has $859,000 Stock Holdings in Barnes Group Inc.
State of Tennessee Treasury Department Increases Holdings in FARO Technologies, Inc.
State of Tennessee Treasury Department Increases Holdings in FARO Technologies, Inc.
State of Tennessee Treasury Department Sells 2,371 Shares of James River Group Holdings Ltd
State of Tennessee Treasury Department Sells 2,371 Shares of James River Group Holdings Ltd


© 2006-2020 Ticker Report